1. Home
  2. SIDU vs CGEN Comparison

SIDU vs CGEN Comparison

Compare SIDU & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$3.68

Market Cap

220.0M

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.18

Market Cap

220.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
CGEN
Founded
2012
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.0M
220.7M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
SIDU
CGEN
Price
$3.68
$2.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
97.1M
589.2K
Earning Date
11-14-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,623,538.00
$6,903,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$100.00
$164.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$1.13
52 Week High
$5.39
$2.66

Technical Indicators

Market Signals
Indicator
SIDU
CGEN
Relative Strength Index (RSI) 58.13 70.53
Support Level $2.88 $1.43
Resistance Level $4.05 $2.01
Average True Range (ATR) 0.85 0.14
MACD -0.09 0.07
Stochastic Oscillator 39.59 81.66

Price Performance

Historical Comparison
SIDU
CGEN

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: